These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9020270)

  • 1. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.
    Johansson JE; Holmberg L; Johansson S; Bergström R; Adami HO
    JAMA; 1997 Feb; 277(6):467-71. PubMed ID: 9020270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natural disease course in untreated early prostatic carcinoma--the Orebro Study].
    Johansson JE
    Praxis (Bern 1994); 2001 Sep; 90(36):1507-14. PubMed ID: 11593906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of early, localized prostate cancer.
    Johansson JE; Andrén O; Andersson SO; Dickman PW; Holmberg L; Magnuson A; Adami HO
    JAMA; 2004 Jun; 291(22):2713-9. PubMed ID: 15187052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of early, localized prostate cancer: a final report from three decades of follow-up.
    Popiolek M; Rider JR; Andrén O; Andersson SO; Holmberg L; Adami HO; Johansson JE
    Eur Urol; 2013 Mar; 63(3):428-35. PubMed ID: 23084329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
    Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
    Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High 10-year survival rate in patients with early, untreated prostatic cancer.
    Johansson JE; Adami HO; Andersson SO; Bergström R; Holmberg L; Krusemo UB
    JAMA; 1992 Apr 22-29; 267(16):2191-6. PubMed ID: 1556796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
    Holmberg L; Bill-Axelson A; Helgesen F; Salo JO; Folmerz P; Häggman M; Andersson SO; Spångberg A; Busch C; Nordling S; Palmgren J; Adami HO; Johansson JE; Norlén BJ;
    N Engl J Med; 2002 Sep; 347(11):781-9. PubMed ID: 12226148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of prostate carcinoma based on a Danish population treated with no intent to cure.
    Borre M; Nerstrøm B; Overgaard J
    Cancer; 1997 Sep; 80(5):917-28. PubMed ID: 9307192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden.
    Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E;
    Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
    Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
    Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20-year outcomes following conservative management of clinically localized prostate cancer.
    Albertsen PC; Hanley JA; Fine J
    JAMA; 2005 May; 293(17):2095-101. PubMed ID: 15870412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term mortality with localized prostate cancer.
    Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
    Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
    Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
    BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in a Swedish population-based cohort of men with prostate cancer.
    Sandblom G; Dufmats M; Varenhorst E
    Urology; 2000 Sep; 56(3):442-7. PubMed ID: 10962312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy versus watchful waiting in early prostate cancer.
    Bill-Axelson A; Holmberg L; Ruutu M; Häggman M; Andersson SO; Bratell S; Spångberg A; Busch C; Nordling S; Garmo H; Palmgren J; Adami HO; Norlén BJ; Johansson JE;
    N Engl J Med; 2005 May; 352(19):1977-84. PubMed ID: 15888698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen levels as a predictor of lethal prostate cancer.
    Fall K; Garmo H; Andrén O; Bill-Axelson A; Adolfsson J; Adami HO; Johansson JE; Holmberg L;
    J Natl Cancer Inst; 2007 Apr; 99(7):526-32. PubMed ID: 17405997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.
    Klotz L; Vesprini D; Sethukavalan P; Jethava V; Zhang L; Jain S; Yamamoto T; Mamedov A; Loblaw A
    J Clin Oncol; 2015 Jan; 33(3):272-7. PubMed ID: 25512465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.